Hudson Bay Capital Management LP Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Hudson Bay Capital Management LP

  • $21.9 Billion
  • Q3 2024

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$7.7 - $37.13 $13,860 - $66,834
-1,800 Reduced 2.4%
73,200 $715,000
Q3 2021

Nov 15, 2021
BUY
$26.46 - $37.15 $1.98 Million - $2.79 Million
75,000 New
75,000 $2.55 Million

Others Institutions Holding DCPH

# of Institutions
6
Shares Held
293K
Call Options Held
500
Put Options Held
0
View Full List

About Deciphera Pharmaceuticals, Inc.

DCPH Quotes by TradingView
  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email